Cellular prion protein (PrP C ), an N-linked glycoprotein, is expressed in a variety of tissues, but its functions remain unclear. PrP C is abundantly expressed in the endocrine pancreas, which regulates blood glucose homeostasis. Therefore, we investigated whether the expression of PrP C was altered in islets of Langerhans in a model of spontaneous type 1 diabetes, the diabetes-prone BioBreeding (BBdp) rat and a model of b-cell adaptation to hyperglycemia, the chronic glucose-infused Sprague Dawley rat. Pancreatic sections from animals aged 7-100 days were stained immunohistochemically and evaluated using light, fluorescence and confocal microscopy. PrP C was ubiquitously expressed in all four major endocrine cell types within islets. Surprisingly, cytosolic inclusions containing PrP C were identified exclusively in a subpopulation of insulin-producing b-cells. The inclusions exhibited different molecular characteristics from the PrP aggregates previously described in vitro in neurons. The frequency of b-cells with PrP C inclusions increased with age and was threefold greater in diabetes-prone rats than in controls at 100 days. Cytosolic PrP C expression in b-cells was suppressed whereas the number and size of PrP C inclusions markedly increased in response to hyperglycemia during the first 2 days of continuous glucose infusion in Sprague Dawley rats. In summary, this is the first report describing in vivo cytosolic PrP C aggregation. These unique PrP C inclusions were b-cell specific, more frequent in diabetes-prone animals, and responded to hyperglycemia in glucose-infused Sprague Dawley rats. These data suggest a potential dysfunction in b-cells of diabetes-prone rats, and point to new avenues for the study of diabetes pathogenesis.
, Diane T Finegood 3 and Fraser W Scott 1, 4, 5 Cellular prion protein (PrP C ), an N-linked glycoprotein, is expressed in a variety of tissues, but its functions remain unclear. PrP C is abundantly expressed in the endocrine pancreas, which regulates blood glucose homeostasis. Therefore, we investigated whether the expression of PrP C was altered in islets of Langerhans in a model of spontaneous type 1 diabetes, the diabetes-prone BioBreeding (BBdp) rat and a model of b-cell adaptation to hyperglycemia, the chronic glucose-infused Sprague Dawley rat. Pancreatic sections from animals aged 7-100 days were stained immunohistochemically and evaluated using light, fluorescence and confocal microscopy. PrP C was ubiquitously expressed in all four major endocrine cell types within islets. Surprisingly, cytosolic inclusions containing PrP C were identified exclusively in a subpopulation of insulin-producing b-cells. The inclusions exhibited different molecular characteristics from the PrP aggregates previously described in vitro in neurons. The frequency of b-cells with PrP C inclusions increased with age and was threefold greater in diabetes-prone rats than in controls at 100 days. Cytosolic PrP C expression in b-cells was suppressed whereas the number and size of PrP C inclusions markedly increased in response to hyperglycemia during the first 2 days of continuous glucose infusion in Sprague Dawley rats. In summary, this is the first report describing in vivo cytosolic PrP C aggregation. These unique PrP C inclusions were b-cell specific, more frequent in diabetes-prone animals, and responded to hyperglycemia in glucose-infused Sprague Dawley rats. These data suggest a potential dysfunction in b-cells of diabetes-prone rats, and point to new avenues for the study of diabetes pathogenesis. KEYWORDS: b-cells; islets; prion protein; diabetes; inclusions; hyperglycemia Cellular prion protein (PrP C ) is expressed mainly in the central nervous system as well as in the pancreatic islets, spleen, testes and other organs. 1, 2 The high conservation of PrP C among mammals infers an essential physiological role. 3 However, the function of this protein is still unclear. One reason is that PrP C knockout mice display no dramatic change in phenotype. 4 To date, several proteins interacting with PrP C have been identified [5] [6] [7] and a picture is emerging of a protein involved in multiple cellular functions including signal transduction, 8 copper metabolism 9 as well as a membrane receptor or ligand. 10 Recently, it has been reported that PrP C is also important for the self-renewal of long-term repopulating hematopoietic stem cells. 11 Furthermore, emerging evidence suggests that cytosolic PrP C is involved in cell survival, but whether it is a cell protective molecule or cell death trigger is controversial. 12 The b-cell is the major cell type within islets of Langerhans with a unique capacity to produce insulin and regulate blood glucose. In type 1 diabetes (T1D), b-cells are selectively destroyed by a progressive inflammatory process called insulitis that involves infiltration of pancreatic islets by mononuclear cells. It is generally thought that the destruction of 80-90% of the b-cells results in hyperglycemia. 13 Some studies suggest that islet defects occur in diabetes-prone animals before islet inflammation. [14] [15] [16] However, the key events leading to immune-mediated b-cell destruction as well as abnormalities in the target b-cells remain unclear.
Although it is known that PrP C is abundantly expressed in the endocrine pancreas, 1, 18 there are no reports linking PrP C and glucoregulation. In addition, PrP C expression has not been described in animal models of diabetes. Therefore, we investigated whether PrP C expression was altered in endocrine cells in the pancreas of diabetes-prone BB rats or Sprague Dawley rats with hyperglycemia induced by chronic infusion of glucose.
MATERIALS AND METHODS Animals
BioBreeding control (BBc) and diabetes-prone BioBreeding (BBdp) rats were purchased from the Animal Resources Division of Health Canada, Ottawa. Wistar Furth rats were purchased from Charles River, Laval, QC, Canada. Animals were maintained under specific pathogen-free conditions and were fed with a standard cereal-based rodent diet. Rats were killed by exsanguination while under anesthesia with 3% isoflurane in oxygen. For immunohistochemistry analysis, tissues were fixed in Bouin's solution or universal molecular fixative (UMFIX, Sakura Tissue-Tek, Torrance, CA, USA), embedded and 5 mm serial sections were cut and attached to charged slides. The degree of insulitis was evaluated on H&E stained pancreas sections as described previously. 19 Pancreatic sections from glucose-infused Sprague Dawley rats were from a study reported by Topp et al. 20 The aim of this study was to evaluate the adaptation of b-cells to hyperglycemia that occurs during chronic glucose infusion. Briefly, male rats were maintained at 221C and 12 h lightdark cycle, with free access to food and water. Under anesthesia, an indwelling catheter was inserted into the jugular and exteriorized from the neck and connected to a flexible tether/swivel system. Rats were infused (2 ml/h) with either 0.45% saline or 50% dextrose in 0.45% saline for 1, 2, 3, 4, 5 or 6 days. Animals were killed while anesthetized with sodium pentobarbital 35 mg/kg i.p., and the pancreas was rapidly removed and fixed in Bouin's solution overnight. For additional details, refer to Topp et al.
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Antibodies and Immunostaining Pancreatic sections were heated in 10 mM citric acid buffer (pH 6.0) in a microwave oven for 10 min to retrieve antigen. All incubation steps with antibodies were performed at room temperature. For PrP C detection, a mixture of six monoclonal mouse anti-PrP antibodies, a gift from AW Stuke (German Primate Centre, Goettingen, Germany), was used. The specificity of these antibodies has previously been reported. 21, 22 We confirmed further the specificity of the PrP antibodies in our laboratory using 22 for 2 h followed by incubation with biotin-conjugated rabbit anti-mouse antibody for 30 min. Thereafter, sections were incubated for 2 h with primary antibodies directed against the proteins mentioned above. Avidin-conjugated Cy3 and FITC-conjugated donkey anti-guinea-pig (DAKO), FITC-conjugated donkey anti-rabbit (DAKO), donkey anti-mouse/Alexa488 (Invitrogen Canada Inc., Burlington, ON, Canada) or donkey anti-goat/Alexa488 (Invitrogen) antibodies were applied for 30 min. Nuclei were stained with Hoechst (Sigma), DR (Biostatus Limited, Shepshed, UK) or SYBR Green I (Molecular Probes, Eugene, Oregon, USA) for 1 min. Zeiss LSM 410 and 510 Meta CLSM microscopes, DRAQ5 (633 nm), Cy3 (565 nm), FITC (505 nm) and Hoechst (395 nm) filters and a Â 63/1.4 oil Plan-Apochromat objective were used to acquire confocal images. A Zeiss Axioplan2 microscope equipped with Â 40/ 0.75 plan Neofluar and a high-resolution IEEE 1394 FireWiret digital CCD color camera (MicroPublisher 3.3 RTV; QImaging, Burnaby, BC, Canada) was used for fluorescence imaging. For negative controls, sections were incubated with the secondary antibodies alone or primary antibodies alone. In each case, negative controls showed no staining on pancreatic sections (Figure 1e-f) . Coincident fluorescent signals, observed using three different color filters, were considered to be autofluorescence.
Three-Dimensional Reconstructions and Orthogonal Projections
The image stacks were obtained using a Zeiss 510 Meta CLSM confocal laser scanning microscope in multitrack mode, a Â 63/1.4 oil Plan-Apochromat objective, and Zeiss Confocal Microscopy Software, Release 3.2. The threedimensional (3D) reconstruction and the orthogonal projection were performed with 'Imaris v.4.1.3' after data deconvolution with 'Huygens Essential'.
Image Analysis
All image analyses were performed as described previously. antibodies (rabbit anti-glucagon, anti-pancreatic polypeptide and anti-somatostatin (1/1500 each)) using AP-conjugated anti-rabbit pAb and BCIP/NBT substrate. This was followed by labeling for PrP C with a mixture of six anti-PrP mAbs (2 mg/ml) using biotin-conjugated anti-mouse pAb, HRPconjugated avidin and DAB as a substrate. Six islets from each section were randomly selected at Â 50 magnification. Images of selected islets were taken at Â 400 magnification and b-cell area was traced and measured. b-Cells containing inclusions from the selected islets were counted. The percentage of cells containing cytosolic aggregates was calculated as follows:
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Statistics
Data are expressed as mean7s.d. or mean7s.e. Student's t-test and ANOVA were used to evaluate the significance of differences between means (GraphPad Prism, Version 4.03). P-values less than 0.05 were considered to be statistically significant.
RESULTS

PrP C Aggregation in Islets of Control and Diabetes-Prone Rats
To investigate whether PrP C expression was altered in the endocrine pancreas in T1D, we first compared the expression of PrP C in islets of diabetes-prone rats with the control, BBc strain aged o50 days. We detected intense PrP C staining in all the endocrine cells of both BBc (Figure 1a ) and BBdp ( Figure 1b ) rats and to a lesser extent in neurons (Figure 1b , black arrow). There was no obvious difference in PrP C staining between the strains in animals younger than 50 days. Surprisingly, we observed cytosolic accumulation of PrP C in aggregates (Figure 1b inset, arrowhead) in islets of both strains. Further evaluation revealed that the number of islet cells with inclusions was increased in animals aged 475 days, and the aggregates were much more pronounced compared with younger animals (Figure 1c) .
Cytosolic aggregation of PrP C in islets was also observed in Wistar Furth (Figure 1d) and Sprague Dawley rats. Thus, a certain level of PrP C aggregation in islets was apparent in several rat strains. We then determined the cellular origin and further characterized the nature of these aggregates.
PrP
C Aggregation in Islets is Unique to b-Cells Pancreatic islets contain four major endocrine cell types, a-, b-, d-and g-cells, which secrete the hormones glucagon, insulin, somatostatin and pancreatic polypeptide, respectively. To determine which cell type possessed inclusions, we performed double immunofluorescence staining of PrP C and each of the four hormones. PrP C inclusions were detected only in insulin þ cells (Figure 2 ). There was no colocalization of PrP C aggregates with glucagon, pancreatic polypeptide or somatostatin positive cells (Figure 2 ). The aggregates were therefore confined to b-cells, the endocrine cell type selectively destroyed in autoimmune T1D. As observed in multiple planes of confocal images stained for insulin and PrP, only a subset of b-cells contained PrP aggregates.
Cytosolic PrP
C Aggregates in b-Cells do not Display Characteristics of Aggresomes Cytosolic protein aggregations are associated with several genetic and degenerative diseases, such as Alzheimer's disease and Huntington's disease. 23,24 Inclusions are often aggregates of misfolded or unfolded proteins that do not bind to each other under physiological conditions. Thus far, cytosolic PrP aggregates have been reported only in studies performed in vitro.
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We performed additional analyses to further characterize the PrP C aggregates in b-cells. All PrP inclusions described in vitro to date were similar to aggresomes. 29 We investigated whether PrP C inclusions in b-cells also possessed characteristics of aggresomes, such as the presence of g-tubulin, vimentin and ubiquitin-proteasome system (UPS).
Each b-cell contained one cytosolic PrP C aggregate. The aggregates were oval and reached a diameter greater than 4 mm in BBdp animals aged 475 days (Figure 3a and Supplementary Figure 1a ; Supplementary Movie 1). They were mainly localized at the cell periphery but were also to some extent perinuclear (Supplementary Movie 2). Immune fluorescence double staining for the PrP C and GM130 Golgi marker revealed that the PrP C concentrated in inclusions did not colocalize with the Golgi apparatus ( Figure  3b and Supplementary Figure 1b; Supplementary Movie 3) . Thus, PrP C was not in the process of being transported through the secretory pathway but was cytoplasmic. Next, we examined whether the aggregated PrP C was associated with the microtubule organization center (MTOC) and UPS. As shown by immunofluorescence labeling, there was no g-tubulin present in the inclusions (Figure 3c and Supplementary Figure 1c) . Thus, the cytosolic PrP C aggregates were not localized to MTOC. In addition, the inclusions did not colocalize with proteasomes and ubiquitin (Figure 3d and e and Supplementary Figure 1d ; Supplementary Movie 4). The finding that PrP C inclusions were not associated with the cellular UPS indicates that they are not recognized as misfolded proteins designated for degradation. Further, PrP C aggregates were not surrounded by vimentin (Supplementary Figure 2) . Thus, the PrP C inclusions in b-cells did not display characteristics of aggresomes.
As the aggresome-like PrP structures described in vitro also colocalized with Hsc70, 26, 27 we addressed whether PrP servations demonstrate that the cytosolic PrP C aggregates in b-cells exhibit distinct molecular characteristics from the aggresome-like PrP structures described in vitro and thus represent a new and unique subcellular PrP C entity.
Cytosolic PrP C Aggregation in b-Cells Increases with Age and is more Frequent in Diabetes-Prone Rats We next investigated whether there was an association between the development of autoimmune T1D and the aggregation of PrP C in b-cells using the BBdp rat, an animal model of spontaneous T1D. The pancreatic histopathology in the BBdp rats closely resembles that seen in human T1D. 30 In BBdp rats from the Ottawa colony, insulitis begins around 50 days of age and is well established by approximately 70 days of age. The average age at onset of T1D is around 90 days. To assess whether the appearance of the inclusions differed between BBc and BBdp rats, we stained for PrP C in sections from animals at 30, 45, 70 and 100 days of age (n ¼ 5-9 per group) and counted cells containing PrP C inclusions (six islets/animal). The number of islet cells containing inclusions increased with age, showing a positive correlation only in BBdp rats (Po0.02) (Figure 4a) . The difference between the rat strains was most striking at 100 days. To assess the exact number of b-cells with inclusions at this age, we double-stained sections from BBc and BBdp animals (n ¼ 9) for PrP C and islet non-b-cell hormones and counted b-cells containing inclusions. The frequency of b-cells with PrP C inclusions was approximately three times greater in BBdp (27.178.2%) compared with BBc (9.873.4%) rats (mean7s.d.; Po0.0001) (Figure 4b and Supplementary Figure 3) . These results strongly suggest that increased formation of cytosolic PrP C aggregates is favored in b-cells of diabetes-prone rats. Interestingly, ganglion cells in the same sections showed remarkably weaker PrP C expression compared with islet cells at all ages and neither ganglion cells nor brain tissue contained PrP C inclusions (Figure 4c and d) .
We also observed a different expression pattern of PrP C at different ages in BBdp and BBc rats. In younger animals (o30 days), PrP C was ubiquitously localized in the cytoplasm and plasma membrane (Figure 4e ), whereas in older animals (475 days), PrP C was mainly localized to the plasma membrane and inclusions. This pattern was particularly evident in b-cells from BBdp animals older than 75 days, which showed strong membrane staining and pronounced cytosolic aggregates of PrP C reaching a diameter up to 5 mm (Figure 4f ).
Cytosolic PrP
C Aggregation in b-Cells Responds to Hyperglycemia b-Cells play a key role in glucose homeostasis. To investigate whether PrP C expression in b-cells was linked to glucoregulation, we investigated the effect of hyperglycemia on PrP C expression in b-cells by analyzing pancreatic tissue from rats infused chronically with glucose, a model of b-cell adaptation to hyperglycemia. 20 We examined the expression pattern as well as cytosolic aggregation of PrP C in b-cells of male Sprague Dawley rats infused with either saline or 50% glucose (2 ml/h) for 0, 1, 2, 3, 4, 5 and 6 days (n ¼ 45 per group).
These analyses revealed that during the first 48 h of glucose challenge, there was nearly complete suppression of cytosolic PrP C expression in b-cells, whereas its expression on the plasma membrane did not change. In contrast, untreated animals displayed a normal expression of cytosolic PrP C in islet b-cells (Figure 5a and b) . Saline-infusion slightly enhanced the expression of cytosolic PrP C in islets. However, it did not result in suppression of cytosolic PrP C or increased formation of aggregates as observed in glucose-infused rats. After 1 day of glucose challenge when blood glucose was B25 mmol/l, cytosolic PrP C in b-cells was almost undetectable (Figure 5c ). The same pattern of cytosolic PrP C expression was observed after 2 days of glucose infusion (blood glucose B25 mmol/l) and pronounced cytosolic PrP C aggregation was identified in b-cells (Figure 5d ). At day three when blood glucose returned to preinfusion levels (B10 mmol/l) b-cells displayed a low expression of cytosolic PrP C . At day 4 and 5, cytosolic PrP C expression increased, reaching the level observed in islets of saline-infused or untreated rats by day 6 (Figure 5e-h) . The size and number of inclusions at day 6 were similar to day 0. Of note, non-b-cells did not show any changes in PrP C expression in response to glucose challenge. In summary, under hyperglycemic conditions, the cytosolic expression of PrP C in b-cells was suppressed while the aggregation was remarkably increased. These results clearly demonstrate that cytosolic expression and aggregation of PrP C in rat b-cells is a physiological process that responds to changes in blood glucose levels.
DISCUSSION
PrP
C is expressed on the cell membrane, anchored to a glycosylphosphatidylinositol moiety in a wide variety of cells and tissues. 1, 2, 11, 31 Its physiological role is still described as a black box, enigmatic and obscure. 6, 32 To our knowledge, there are only two reports describing the expression of PrP in islet cells. 18, 33 However, the expression of PrP C in islets of Langerhans has not been linked with glucoregulation nor has it been reported in animal models of diabetes.
In this study, we demonstrate that PrP C is strongly expressed in islets and forms b-cell-specific cytosolic aggregates. Infusion with glucose specifically altered cytosolic PrP C expression in b-cells. There is only one report linking expression of PrP C and glucose concentration. 34 Hypoglycemic conditions resulted in an upregulation of PrP C expression in N18 mouse neuroblastoma cells in the first 24 h followed by a decline. In the present study, the expression of cytosolic PrP C in b-cells of Sprague Dawley rats decreased after the first 24 h of glucose challenge, and gradually returned to normal levels after 4 days. Topp et al 20 reported that blood glucose in the infused animals was highest (B25 mmol/l) on day 1 and 2 and decreased by day 3. Insulin increased B12-fold during the first 24 h and remained B8-fold higher than control values by day 5. These data clearly show that the suppression of cytosolic PrP C expression and increased aggregation in rat b-cells was influenced by blood glucose concentration. The lack of colocalization of Hsc70, ubiquitin and proteasomes with the aggregates is consistent with the proper folding of PrP C within the inclusions. Thus, the inclusions may function as storage depots to sequester excess cytosolic PrP C in b-cells during periods of high blood glucose.
As we detected moderate cytosolic PrP C aggregation in several rat strains, we propose that the aggregation of PrP C in rat b-cells is a normal physiological process possibly associated with blood glucose regulation. The significantly higher proportion of b-cells with PrP C inclusions and pronounced PrP C aggregation in BBdp rats aged 450 days, when islet inflammation becomes visible, could be associated with dysregulated blood glucose. Interestingly, we did not observe a correlation between insulitis score and the number of inclusions in b-cells of BBdp rats. This indicates a previously unrecognized dysfunction in b-cells of BBdp rats that could precede autoimmune b-cell destruction, a point that requires additional evaluation. In accordance with our findings, results from human 35 and animal 36 studies also suggest that aberrant b-cell activity might precede diabetes.
In conclusion, this study demonstrates altered metabolism of PrP C in b-cells in two animal models associated with glucose dysregulation. We show for the first time the in vivo accumulation of PrP C in cytosolic inclusions, which were restricted to b-cells in pancreatic islets. These cellular PrP C aggregates have different molecular characteristics from the cytosolic aggresome-like inclusions of PrP described previously in vitro [26] [27] [28] and thus, reveal a unique subcellular PrP C structure. The appearance of the inclusions was age dependent, and more frequent in BBdp rats compared with the control strain. Moreover, hyperglycemic conditions resulted in pronounced accumulation of PrP C in inclusions. These findings suggest a previously unrecognized physiological role for PrP C in b-cells that is closely associated with glucose homeostasis. Our data raise the possibility of a b-cell dysfunction in BBdp rats that precedes the development of islet inflammation. These intriguing associations could shed further light on the physiological processes leading to both diabetes and prion diseases.
